The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors by Richards, M et al.
Editorial
The National Cancer Survivorship Initiative: new and emerging
evidence on the ongoing needs of cancer survivors
M Richards*,1, J Corner
2,3 and J Maher
3
1National Cancer Action Team, 18th Floor Portland House, Bressenden Place, London SW1E 5RS, UK;
2Faculty of Health Sciences, University of
Southampton, Building 67, Highfield Campus, Southampton SO17 1BJ, UK;
3Macmillan Cancer Support, 89 Albert Embankment, London SE1 7UQ, UK
British Journal of Cancer (2011) 105, S1–S4; doi:10.1038/bjc.2011.416 www.bjcancer.com
& 2011 Cancer Research UK
                
A key commitment of the Cancer Reform Strategy (Department of
Health, 2007) in UK, and endorsed in Improving Outcomes
Strategy for Cancer (Department of Health, 2011), was to establish
a National Cancer Survivorship Initiative (NCSI). The initiative
was launched in January 2010 and is co-led by the Department of
Health and Macmillan Cancer Support with the involvement of
a large range of stakeholders. The Improving Outcomes Strategy
for Cancer recognises that not enough attention has been given to
the long-term consequences of a cancer diagnosis for the ever
increasing number of individuals surviving the disease, or as to
how to enable individuals to return to active lives following the
completion of initial cancer treatment. The Survivorship Initiative
has set out to understand the needs of those living with cancer and
develop models of care that meet their needs, the goal being to
support cancer survivors to live as healthy and active a life as
possible, for as long as possible. The NCSI sets a vision based on
five shifts in care and support for people living with and beyond
cancer (Figure 1).
A core focus for the NCSI has been to engage members of the
research community to review and develop the evidence in relation
to the needs of cancer survivors and the most effective models of
services, care and support to address these. A major issue for the Initi-
ative has been the lack of UK data and evidence relating to the health
outcomes (other than survival) for individuals following primary
treatment for cancer. The need to stimulate a new field of enquiry to
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this supplement to the British Journal of Cancer is to bring together
new and emergent research in the field of cancer survivorship.
CANCER SURVIVORSHIP: A NEW FIELD OF ENQUIRY
It is both a tribute to the success of cancer research and treatment
over the last 40 years and an indictment of these efforts that we need
a National Cancer Survivorship Initiative. Over the period, long-
term survival for individuals diagnosed with cancer has doubled and
there is now a life expectancy of 10 years or more for the majority of
individuals with some common cancers (although there are notable
exceptions in lung and pancreatic cancers where survival rates
remain stubbornly poor; CRUK, 2010). These developments are
transforming the experience of cancer from one where in the past
the disease inevitably signalled a potentially life-threatening illness
to one where today we are beginning to think of cancer in certain
circumstances as a long-term, even a ‘chronic’ illness (Tritter and
Calnan, 2002). Nevertheless, in 2007, when work for the Survivor-
ship Initiative began, we had no recent epidemiological data relating
to the number of individuals living with a cancer diagnosis in the
UK; less importance was attributed to measuring prevalence than to
incidence, survival and mortality as core measures of cancer
outcomes, and there were no data relating to broader dimensions of
health outcomes among cancer survivors. Since 2007, work has
commenced to fill in these gaps and the results of these efforts are
presented in a number of papers in this supplement. Evidence from
this early work indicates concerns over the short- and long-term
health outcomes for individuals following initial cancer treatment
and suggests that great attention needs to be paid to this as part of
routine cancer management. However, there has been insufficient
data available to provide detailed evidence as to how best to address
these concerns or the specific actions that should be taken to
improve services or care.
If health outcomes for cancer survivors are to be improved, we
need answers to the following questions:
1. How many people are currently living with a cancer diagnosis,
and how is this likely to change over time?
2. What is the state of health and well-being of cancer survivors,
and how does this compare with that of people with or without
other long-term conditions?
3. What specific problems, concerns or needs do cancer
survivors report at different times after diagnosis and at
different phases in the pathway of care?
4. What are the risks of survivors experiencing adverse
consequences from cancer treatment at different time intervals
after diagnosis?
5. What care are cancer survivors currently receiving from the
NHS in hospitals and in the community?
6. How do cancer survivors perceive the care they currently
receive and what are their preferences for future care?
7. What interventions have been shown to improve health
outcomes for cancer survivors?
8. How can survivorship care best be delivered?
9. What do we not know that should form priorities for future
research?
10. How can research in this important field best be supported?
The papers included in this supplement start to address these
questions, particularly from a UK perspective.
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Maddams et al (2009) have previously reported a pivotal study
indicating that around 2 million people were alive in the UK
following a diagnosis of cancer at the end of 2008, and that this
figure will rise by 3% each year. Breast, colorectal and prostate
cancer account for a large proportion of all cancer survivors.
In this supplement, Maher and McConnell (2011) build on
the overall prevalence figures for breast, colorectal and lung
cancer to estimate the numbers of patients likely to be alive at
different phases of the survivorship care pathway. At present,
cancer registries in the UK do not routinely collect data on
date of recurrence or metastasis, and thus these estimates
rely on a number of clinically led assumptions. However,
the broad estimates should provoke thought and may be helpful
for service planners. Collection of data on date of recurrence
is now being piloted by breast cancer teams in this country,
working with cancer registries. It is anticipated that this work will
be extended to other cancers. Refinements of the estimates made
by Maher and McConnell should therefore be possible in the
future.
HEALTH AND WELL-BEING OF CANCER SURVIVORS
In 2008, a national population-based survey was undertaken to
compare the self-reported health and well-being of individuals
with a cancer diagnosis with individuals who had not been treated
for cancer, as well as with individuals with other serious chronic or
long-term conditions. The survey revealed relatively poorer health
and well-being and relatively higher use of hospital services among
individuals who had a former cancer diagnosis when compared
with individuals who had no cancer diagnosis. Initial data from the
survey were reported in the NCSI Vision report (Department of
Health, Macmillan Cancer Support, NHS Improvement, 2010). In
this Supplement, Elliott et al (2011) report for the first time a
detailed secondary analysis of these data and provide evidence that
the health profiles of cancer survivors are broadly similar to those
with a serious long-term condition. In addition, individuals
formerly diagnosed with cancer and who also report a chronic
illness are in poorer health still. It is, however, important to note
that a significant number of cancer survivors report excellent or
good health.
PROBLEMS AND CONCERNS OF CANCER SURVIVORS
The study reported by Foster and Fenlon (2011) in this supplement
highlights a relatively under-recognised problem experienced by a
significant number of cancer survivors. This is loss of self-
confidence, which may be a particular issue in the period shortly
after completion of primary treatment. Foster and Fenlon (2011)
reveal how recovery from primary cancer treatment requires a
rebuilding of lost confidence and how cancer survivors may
struggle where confidence is low or appropriate support is lacking;
indeed, this loss of self-confidence may itself be a significant
barrier to accessing support. The authors argue that regaining or
recovery of lost self-confidence is an important aspect of recovery
alongside physical and psychosocial problems, and that this
requires a supportive infrastructure. Programmes that aim to
promote rehabilitation and supported self-management should
take account of this. Importantly, Foster and Fenlon (2011) have
incorporated learning from their research into the design of a
study of recovery of health and well-being in a cohort of 1000
colorectal cancer survivors recently launched by the Macmillan
Survivorship Research Group at the University of Southampton.
CONSEQUENCES OF TREATMENT
Khan et al (2011a) have used the General Practice Research
Database to explore the incidence of long-term consequences of
cancer treatment among 26000 patients diagnosed with breast,
colorectal or prostate cancer at least 5 years earlier. Using a case–
control design, the authors have identified increases in heart
failure, coronary heart disease, osteoporosis, diabetes and
hypothyroidism among cancer survivors. This study demonstrates
the potential of using routinely recorded electronic data from
primary care to explore the patterns of ill health experienced by
cancer survivors. The use of linked data from primary and
secondary care together with information from cancer registries
should, in future, facilitate more detailed analyses of risk factors
related to specific aspects of anticancer treatment.
HEALTH SERVICE UTILISATION
Maddams et al (2011a) have built on their previous work on cancer
prevalence to assess health service utilisation among cancer
Five shifts in care and support for people living with and beyond cancer:
1. A cultural shift in the approach to care and support for people affected by cancer–
    to a greater focus on recovery, health and well-being after cancer treatment.
2. A shift towards holistic assessment, information provision and personalised care
    planning. This is a shift from a one-size fits all approach to follow-up to personalised
    care planning based on assessment of individual risks, needs and preferences.
3. A shift towards support for self-management. This is a shift from a clinically
    led approach to follow-up care to supported self-management, based on
    individual needs and preferences. This approach empowers individuals to take on
    responsibility for their condition supported by the appropriate clinical assessment,
    support and treatment.
4. A shift from a single model of clinical follow-up to tailored support that enables
    early recognition of the consequences of treatment and the signs and symptoms of
    further disease as well as tailored support for those with advanced disease.
5. A shift from an emphasis on measuring clinical activity to a new emphasis on
    measuring experience and outcomes for cancer survivors through routine use of
    patient-reported outcome measures in aftercare services.
Figure 1 The National Cancer Survivorship Initiative for England Vision (Department of Health, Macmillan Cancer Support, NHS Improvement, 2010).
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episode statistics. They have previously demonstrated that the
overwhelming majority of inpatient admissions among cancer
patients occur in the first year after diagnosis or in the year before
death (Maddams et al, 2011b). In this supplement, the same
authors explore the extent to which these admissions are related or
unrelated to the diagnosis of cancer at different periods following
diagnosis. Although the majority of hospital activity is in the first
year following diagnosis, a significant amount of admissions occur
for all cancer survivors in years 1–5, particularly for lung and
colorectal cancer, and is indicative of the ongoing needs of cancer
survivors. This study also reveals that older cancer survivors (over
75 years) have a higher-level hospitalisation and this is particularly
the case for prostate cancer.
PERCEPTIONS AND PREFERENCES FOR CARE
In parallel with their large-scale quantitative study described
above, Khan et al (2011b) have undertaken qualitative interviews
to explore perceptions of primary-care services among cancer
survivors. Although cancer survivors described ongoing needs
for information and support that could potentially be provided
by GPs, they reported little involvement by GPs in their care. In
addition, GPs were perceived by patients as lacking the necessary
expertise in cancer management.
INTERVENTIONS TO ENHANCE HEALTH OUTCOMES
Davies et al (2011) present a review of the literature on the role of
diet and physical activity in breast, colorectal and prostate cancer
survivorship. This highlights the importance of physical activity
in protecting against cancer recurrence and progression, with a
dose–response for better outcomes. When taken with findings
from a previous systematic review undertaken by the World
Cancer Research Fund (Bekkering et al, 2006), evidence suggests
that the mechanism of benefit from diet and physical activity
relates to weight, with excess weight being a risk factor for
recurrence. The challenge now will be to use this research evidence
to promote better outcomes among large numbers of cancer
survivors.
SERVICE DELIVERY LEVELS
The National Cancer Survivorship Initiative is exploring a range
of new models of care for patients at different phases of the
survivorship pathway. These include new approaches to assess-
ment and care planning, providing advice and support on healthy
lifestyles, alternatives to routine follow-up and new models of care
for patients with late effects of treatment. To assess the impact of
new interventions and service delivery models, it is becoming
increasingly important to develop electronic capture of quality-of-
life data on cancer survivors. This is already needed for research,
but it is likely that this will become a routine part of clinical
practice in the future. In order for this to happen, technical
platforms are required to collect patient-reported outcome
measures on large numbers of patients. In this supplement, Ashley
et al (2011) detail the steps being taken to develop and assess one
such platform (EPOCS).
PRIORITIES FOR FUTURE SURVIVORSHIP
RESEARCH
A systematic review of current research evidence relating to
survivorship was commissioned as part of the NCSI in order to
identify priorities for future research. Richardson et al (2011)
publish the findings from this review in this supplement. These
findings have already informed the development of an action plan
for promoting research in this field by the UK National Cancer
Research Institute (NCRI, 2010). The highest priority areas for
research are identified as follows:
 Delineating the natural history of survivorship
 Creating tools to identify the risk of an individual developing
ongoing problems following primary cancer treatment
 Health services research and economic assessment of care
pathways for cancer survivors
 Studies investigating the psychological and social impact of
cancer
 Studies investigating ongoing physical symptoms experienced
by cancer patients as a consequence of cancer treatment
SUPPORT FOR SURVIVORSHIP RESEARCH
Several years ago the National Cancer Research Institute
identified support for research into supportive and palliative care
as being a high priority (NCRI, 2004). This led to the establishment
of two research collaboratives: CECo (www.ceco.org.uk) and
COMPASS (www.compasscollaborative.com). During 2009–2010,
the NCRI undertook a rapid review of research in this area
(NCRI, 2010) as part of the National Cancer Survivorship
Initiative. A key aim of this review was to integrate the strategies
of government and charity sector research funders in these
areas. The review highlighted the great progress made since
2004, including the expansion of research capacity and the
generation of a culture of collaboration of cross-disciplinary and
multi-institutional working. Further support to build and sustain
research in this area is now being undertaken under the auspices
of NCRI.
SUMMARY
In summary, new models of care are needed to optimise health-
related quality of life among cancer survivors. The development
of these models depends critically on high-quality research.
Until recently, this field of cancer research has been relatively
underdeveloped both within the UK and elsewhere. There are
methodological challenges as the infrastructure for gathering
information on long-term health outcomes as part of routinely
collected data in the NHS is in the process of being established,
and data relating to key problems and measures of these are still
emerging. The number of research groups pursuing questions
related to cancer survivorship is small at present and needs to
increase as does the investment in research that will address the
10 questions highlighted in this editorial. The studies reported in
this supplement show that important work is now underway
in this country. This is already informing thinking within the
NCSI, but many important questions remain unanswered.
Further development of research in this field should remain a
high priority.
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